Influence of Sodium Intake in spondyLoarthriTes
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorCentre Hospitalier Universitaire de Besancon
About this trial
The aim of the SALT study is to analyze the relationship between dietary sodium intake and disease activity in patients with axial spondyloarthritis (radiographic or non-radiographic) or psoriatic arthritis.
Eligibility criteria
Qualifiers
patients with axial spondyloarthritis (radiographic or non-radiographic) or psoriatic arthritis
women who have been menopausal for at least 24 months, surgically sterilized, or, for women of childbearing potentiale, use an effective method of contraception (oral contraceptives, contraceptive injections, intrauterine devices, double-barrier method, contraceptive patches)
Disqualifiers
patient treated by cyclosporine, diuretics, angiotensin-converting enzyme inhibitors or angiotensin II receptor antagonists.
current treatment with an anti-IL-17A agent (secukinumab or ixekizumab or bimekizumab or brodalumab) or with an anti-IL23 agent (ustekinumab, guselkumab, risankizumab or tildrakizumab) or previous treatment less than 6 months old.
patients on systemic corticosteroids with corticosteroid therapy > 10 mg prednisone equivalent
pregnant woman
Trial design
Treatments tested in this trial
- measurement of salt intake
Treatment groups
250 Participants
are divided into 1 treatment groupLocations
4CHU Besançon25000, Besançon France
CHD Vendée85000, La Roche-sur-Yon France
CHU St Etienne42000, Saint-Etienne France
Hôpital Nord Franche-Comté90400, Trévenans France
Sponsors and collaborators
Centre Hospitalier Universitaire de Besancon
Lead sponsor
French Society of Rheumatology
Collaborator
Source ClinicalTrials.gov